-Scroll.in One of India’s most renowned epidemiologists cautions against unsustainable lockdowns and says community participation is the key to fight the disease. Jayaprakash Muliyil is one of India’s foremost epidemiologists, with decades of experience in the study of infectious diseases. The former principal of the Christian Medical College in Vellore spoke to Scroll.in about India’s response to the coronavirus outbreak. He said the stage of community transmission, when the source of infection for...
More »SEARCH RESULT
Total Matching Records found : 977
Coronavirus: China trial found no benefit in HIV Drugs, says study -Abantika Ghosh
-The Indian Express At 22.1 per cent, the mortality reported in the trial was substantially higher than the 11 per cent to 14.5 per cent mortality reported in initial studies of patients hospitalised with novel coronavirus (COVID-19), according to a study. The results of a 199-subject trial in China on the efficacy of HIV Drugs Lopinavir and Ritonavir that India was looking at eagerly, has come out negative. At 22.1 per cent, the...
More »Price of new lifesaving TB drug, Pretomanid, too high, says MSF -M Somasekhar
-The Hindu Business Line The drug was developed by the TB Alliance, funded by various governments and philanthropic sources Hyderabad: The slew of newer TB Drugs that have hit the market recently promise to tackle the disease better, but the high price can prove a dampener to realise the goal of taming the deadly disease on a war footing, feel experts, advocacy groups and medical organisations who are meeting this week in...
More »Explainer: What Abhijit Banerjee, Esther Duflo, Michael Kremer won the Economics Nobel for -Jahnavi Sen and Kabir Agarwal
-TheWire.in All three winners argue that using randomised control trials can lead to better public policy interventions. New Delhi: The 2019 Nobel Prize for economics has been awarded to three economists who have focused on framing policies by first measuring the outcomes of alternative interventions on randomly chosen samples from a target population. Abhijit Banerjee, Esther Duflo and Michael Kremer have all worked on using this method to argue that randomised control trials...
More »Shamnad Basheer's work in IP, academia, holds survival lessons for the liberal edifice -Pritam Baruah
-The Indian Express Basheer’s energy shines through in his multi-dimensional academic career, which was marked by controversies and pathbreaking achievements. Inhabiting dualities defined Shamnad Basheer. Nicola Lacey, biographer of the eminent legal philosopher H L A Hart, wrote that Hart was surely an insider to Oxford philosophy, but always saw himself on the margins. Memories of Basheer kindle something similar: Inspiring students, intervening socially, recognised publicly and yet, secluded and distant....
More »
